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The ability of phage FR38 to lysis indigenous Salmonella P38 from feces of diarrheal patient has been studied.
However, effects of phage FR38 on organ system were not revealed as yet. This study was conducted to observe the
effect of phage FR38 on blood chemistry, kidney functions, and liver functions. Twelve Sprague-Dawley rats were
used as a model for this study that were divided into two groups; (i) control and (ii) treated group with phage FR38.
For treated phage group, each rat was administered by 5 ml/kg bw of 1.59·107 pfu/ml of phage intragastric. The
blood parameters were analysed on day 16. The results revealed that body and organs weight, erythrocyte,
hematocrit, hemoglobin, leukocyte, total protein, creatinine, SGOT, and SGPT of phage treatment rats were not
significantly different with the control rats on day 16 (P > 0.05). Therefore, this study showed was no effect of
phage FR38 on body weight, blood chemistry, kidney and liver functions of the rat (P > 0.05).
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INTRODUCTION
Salmonella is a food borne pathogenic bacteria that
cause food borne and water borne disease (Delibato 2006).
Salmonella were used as an indicator of food hygiene
and food safety (Abedon 2008). Salmonella P38 that
performed antibiotic resistant had been isolated from feces
of diarrheal patient.
Contamination of Salmonella on food had been
reported in orange juice and fresh orange (Castillo et al.
2006), apple cider product (Zhuang et al. 2005), beverage
product (Li & Mustapha 2005), milk (Tadesse et al. 2005),
apple juice (Izzo & House 2011), and fresh shrimp  (Ray
(2001). In Indonesia, chemical preservatives mostly were
used to decrease microbe, however the chemical
preservatives showed toxic effect. Food producers
currently used illegal preservative such as, formaldehyde,
aluminate and hydrogen peroxyde due to the high price
of the legal preservatives. Illegal preservative, such
formaldehyde, also cause a negative effect on organ and
body cell. Base on presentation upon, other alternative to
decrease microbe on food is needed.
Phage lytic is a preservative alternative on food
processing (Rode et al. 2011), have an environmentally-
friendly characteristic (Castro et al. 1991), non toxic and
is easy to be isolated, such as from humans, cattle, pigs,
and chickens (Duijkeren et al. 2002)  and can be produced
(Brenner et al. 1991; Maura & Debarbieux 2011). Phage
lytic can be isolated from the environment as well such as
soil, water, human body, fermented food (Lu et al. 2003a),
vegetable fermentation (Lu et al. 2003b) and food
products. Isolate of phage lytic can be taken from various
food products e.g. cheese and yoghourt (Binneti &
Reinheimer 2000), salad, crisp and lettuce (Kennedy 1986).
Phage application as a biocontrol food had been used
to decrease a microbe contaminant on food, such as,
Bacillus cereus phage in outbreaks of food poisoning
(Ahmed et al. 1995), psychrotrophic phage to prevent
spoilage process on food (Greer 2005), Xanthomonas
phage to prevent a spot on tomato (Flaherty 2000), Listeria
phage (Leverentz et al. 2004) and Salmonella enteriditis
phage on melon and apple slices (Leverentz et al. 2001).
Staphylococcus aureus phage also had been applied on
milk as well as Salmonella enteritidis phage on cheese
(Greer 2005), E. coli phage on beef steak  (O’Neill et al.
2001) and on food processing (Rode et al. 2011),
Flavobacterium columnare phage on fish (Laanto et al.
2011), Listeria and E. coli phage on meat (Anani et al.
2011), and on milk (ellis et al. 1973).
The other application of phage was as a microbe
therapy (Chairns & Payne 2009), such as, by using
Salmonella enterica phage (Pang et al. 2011), Yersinia
pestis (Schofield et al. 2009), cancer cell (Browska et al.
2010), Mycobacterium phage (Foddai et al. 2011), Vibrio
cholerae phage (Chakrabarti et al. 2000), Actinomycetes
phage (Nerney et al. 2004), phage of methicillin resistant
S. Aureus (O’Neill et al. 2001; Murchan et al. 2004),
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Bacillus antrachis phage (Abshire et al. 2005), Listeria
monocytogenes  phage (Kim et al. 2012), phage of bacterial
resistance to antibiotic (Edgar et al. 2011), and E. coli
O18:K1:H7 phage (Bull et al. 2011). Phage therapy on
poultry had been done by using of Salmonella enteriditis
phage Sillankorva et al. (2010). The result of Budynek et
al. (2010) points out that phage therapy on cancer patient
can decrease the incident of microbe infection
significantly. Ghaemi et al. (2010) reported that phage
therapy on tumor can be done by use of λ-phage. Budiarti
et al. (2011) reported that EPEC (Enteropathogenic
Escherichia coli) can be degraded by phage isolated from
the environment.
On preliminary study, phage FR38 had been used to
decrease of Salmonella P38, an indigenous contaminant,
on fresh milk and sausage. Nevertheless, the effect of
phage FR38 on body damage was still unrevealed.
Therefore, the aim of this study was to observe the effect
of Salmonella P38 phage (phage FR38) on organs system
by use Sprague Dawley’s rat as the animal model.
MATERIALS  AND  METHODS
Phage Production. Palette of Salmonella P38
indigenous culture (OD=1) 108 cfu/ml were dropped by
phage FR38 (1 ml) (collection of the second author), and
were incubated at 37 oC for 30 minutes. The cocktail of
Salmonella P38 phage were cultivated  in 49 ml of nutrient
broth (NB) medium, and incubated at 37 oC for 24 hours.
After 24 hours incubation, bacteria-phage cocktail were
centrifugated with 2800 rpm speed (Backman GPR
Centrifuge), at 4 oC for 20 minutes. Supernatant (3 ml) were
taken by using a 5 ml syringe and filtered by using
Millipore membrane 0.22 μm (Whatmann). The
supernatant from filtration process were transferred into
sterile tube (Clokie & Kropinski 2009). After double overlay
process, the phage were counted by use Clokie and
Kropinski formula, i.e., phage total = 1.59·107 + 2.449·107
pfu/ml (Figure 1).
Experimental Design. A total of 12 Sprague Dawley
rats, all were in the same two months age rats were obtained
from Veterinary Medicine Faculty, Bogor Agricultural
University. Experimental rats were aclimitated at rat cage
for 15 days, and then divided into two groups. The first
group was rats as control and the other group was
given by phage treatment. During adaptation, all of rat
was fed with Japfa animal feed with standard drink (Table
1).
Research designs were the randomized control group
post test design. The treatments of this research were
control and phage treatment (5 ml phage FR38/kg bw; 1 ml
= 1.59 x 107 pfu). Layout of experiment was arranged by
coding of the sample, such as, control treatment code
(K1, K2, K3, K4, K5, and K6) and phage treatment code
(P1, P2, P3, P4, P5, and P6). After treatment coding, rat
code were placed in random position (Table 2).
Phage Treatment. All rats were weighed and were
labeled with treatment codes. Body weights of rats were
measured every two days for 15 days. The doses of
treatment were (i) control group and (ii) Phage FR38 group.
Each group was administered (5 ml kg-1 bw) by phage
FR38 every day for 15 days.
Intragastric Administration. Treatment on rat (control
group and Phage FR38 group) was carried out using 16 G
intra-gastric syringe. For safety intra-gastric
administration, the syringes were manipulated and added
a bulbed needle.
Data Administration. After given the treatment for 15
days, data collected on day 16 by surgical technique on
rat’s body. The euthanasia processes of rat were used
ether. The blood was taken from the posterior vena cava.
The blood chemistry was analyzed for red cell
(erythrocyte) and white cell number, hemoglobin,
hematocrit, leukocyte differentiation (lymphocyte,
neutrophil, eosinophil, and basophil), Serum Glutamic
Table 1. Feed and treatment given to the rats
                                                                                                                                Treatment Period (for 15 days)
                                                                                                                      Feed                                                 Treatment
Adaptation period (for 14 days)Treatment
Control
Phage
Feed
Platelet from Jafpa
Feed
Platelet from Jafpa
Drink
phage = 1 ml/200g bw
Table 2. Treatment and lay out design
Lay out design
Location code  Control lay out  Location code  Treatment lay out
K4
K5
K1
K6
K3
K2
1
2
3
4
5
6
7
8
9
10
11
12
P 2
P 1
P 6
P 5
P 3
P 4
 
Phage plaque
Figure 1. The appearance of plaque phage FR38.
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Oxaloacetic Transaminase (SGOT), Serum Glutamic
Pyruvic Transaminase (SGPT), creatinin, and total protein
(Djojosoebagio 2007). The performances (shape and color)
of rat feces also were collected for 16 days.
Statistical Analysis. Statistical analysis was carried
out using Student’s t-test. The results were presented as
the mean differences between individual groups with P
(less than or equal to) 0.05 consider statistically significant.
RESULTS
     Body Weight. Body weights of rat were not significantly
different for each group. We found that not significantly
different in body weight between the two group treatments
(P > 0.05) on day 0, 2, 4, 6, 8, 10, 12, 14, and 16. The average
values of the body weight for each group were presented
in Table 3. The body weight of phage treatment and control
rat showed a normal growth characteristic. On day 1, the
mean values of body growth control rat was 214.5 g (n =
6) and the body growth phage treatment rat was 212 g (n
= 6).  In the fact, the phage and control treatment, on day
1 up to 16, showed not significantly effect on body weight
(P > 0.05) with the mean values of control rat was 250.47 g
(n = 6) and  phage FR38 rat was 255.83 g (n = 6). All of the
phage treatment rats shown that the body growth rats
were also tend in normal characteristics. The body growth
of all controls the same high as all treatment rats. On the
last treatment day, the body growth of phage treatment
(SD = 8.295) and control (SD = 8.710) rat were uniform
(Table 3).
Feces. Data of feces performances on day 0, 2, 4, 6, 8,
10, 12, 14, and 16 showed no difference among rats which
had given by phage FR38 treatment and control (Table 4).
The feces of phage FR38 rat and control rat were normal
on day 0 up to 16.
Organ Weight. Large intestine, spleen, right kidney,
left kidney, stomach, small intestine, heart, lung  and liver
weight the same for the groups (P > 0.05) on day 16 (Table
5). The organ weight of phage treatment was normal as
well.
Erythrocyte. Hemoglobin and erythrocyte of rat blood
for 16 day were not different for each group (control and
phage group). We found not significantly effect in
hemoglobin and erythrocyte in the two group treatments
(P > 0.05). Hemoglobin number of control rat (n = 6) was
similar as the phage treatment rat (n = 6) (P > 0.05) on day
16 day. Erythrocyte of control rat (n = 6) was as much as
those in phage treatment rats (n = 6) (P > 0.05) on day 16.
Median values of the hemoglobin and erythrocyte for each
rat groups were presented in Table 6. Hematocrit value of
control rat (n = 6) was also the same as phage treatment
rat (n = 6) (P > 0.05).
The research results showed that thrombocyt value
was not significantly different in the two group treatment
(P > 0.05). Thrombocyt value of control rat (n = 6) was as
much as phage treatment rat (n = 6) (P > 0.05) (Table 6) on
day 16.
Leukocyte.  Leukocyte total number of control rat was
not significantly different in the two group treatments (P
> 0.05). In this research, we also observed the
Table 3. Effect of phage treatment on body weight of rat
Day                          Control (g)                   Phage treatment (g)
0
2
4
6
8
10
12
14
16
214.5 + 3.782a
217.55 + 4.579b
219.86 + 5.317c
224.19 + 6.156d
227.78 + 6.494e
233.47 + 7.360f
239.05 + 5.007g
244.3 + 8.335h
250.47 + 8.710i
212.00 + 1.291a
219.33 + 4.308b
223.16 + 2.409c
227.17 + 2.671d
232.67 + 5.153e
237.83 + 4.524f
244.33 + 4.642g
248.83 + 5.757h
255.83 + 8.295i
The same letter in each row indicated not significantly different
at P > 0.05.
Table 4. Effect of phage treatment on rat feces
                                                                                                     Day
                                  0                  2                 4                   6                 8                   10                 12                  14              16
                          Fs                  Fs                Fs                 Fs                 Fs                  Fs                 Fs                   Fs                Fs
Treatment
F1
F2
F3
F4
F5
F6
K1
K2
K3
K4
K5
K6
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N = Normal.
Table 5. Effect of phage treatment on organ weight values of rat
Organ                        Control (g)       Phage FR38 treatment (g)
Large intestine
Spleen
Right kidney
Left kidney
Stomach
Small intestine
Liver
Lung
Heart
22.573 + 2.292a
0.702 + 0.100b
1.852 + 0.093c
1.822 + 0.129d
9.760 + 1.615d
7.007 + 0.776e
10.103 + 0.761f
1.992 + 0.126g
0.813 + 0.065h
21.683 + 1.951a
0.673 + 0.210b
1.842 + 0.055c
1.840 + 0.069d
7.065 + 1.845d
6.872 + 1.529e
10.002 + 0.798f
1.970 + 0.204g
0.807 + 0.070h
The same letter in each row indicated not significantly different
at P > 0.05.
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differentiation of white cell blood, such as, neutrophil,
monocyte, eosinophil, lymphocyte, and basophil. The
monocyte values of control rat were not significantly
different in the two group treatment (P > 0.05). The
monocyte value of control rat (n = 6) was as much as
phage treatment rat (n = 6) (P > 0.05) on day 16 (Table 6).
The number of neutrophil after given the phage
treatment was not increased. The neutrophil values of
control rat showed not significantly different in the two
group treatment (P > 0.05). The neutrophil value of control
rat (n = 6) was as much as phage treatment rat (n = 6) (P >
0.05) on day 16.  The result point out that the eosinophil
count of controls (n = 6) showed not different value with
the phage treatment (n = 6) on day 16 (P > 0.05). The
basophil values of control rat also showed not significantly
different in the two group treatments (P > 0.05). The
neutrophil value of control rat (n = 6) as much as phage
treatment rat (n = 6) (Table 6).
Lymphocyte value was not significantly  different in
the two group treatment (P > 0.05). The lymphocyte value
of control rat (n = 6) as much as phage treatment rat (n =
6). Median values of the hemoglobin, hematocrit and
erythrocyte for each rat group are presented in Table 6.
Total Protein. The value of protein total shown a total
of  the globulin and albumin value. Overall structure of
the immunoglobulin molecule was determined by the
sequence of amino acids. In this research, the protein total
value was not significantly different in the two group
treatment (P > 0.05). Protein total value of control rat was
(n = 6) was as much as phage treatment rat (n = 6) (P >
0.05) (Figure 2) on day 16.
Kidney Functions. Kidney functions parameter can
be observed from blood, such as, creatinine. Increasingly
of creatinine on the blood indicate an abnormal of kidney
function. The result showed that the creatinine value was
also not significantly different in the two group treatment
(P > 0.05). The creatinine value of control rat (n = 6) as
much as phage treatment rat (n = 6) on day 16 (P > 0.05)
(Figure 3).
Liver Functions. Liver functions parameter can be
observed from blood, such as, SGOT and SGPT values.
Increasing of SGOT and SGPT on the blood indicate an
abnormal of liver function. The result research showed
that SGOT and SGPT value were also not significantly
different between the two group treatments (P > 0.05).
SGOT value of control rat (211.67 + 65.503 IU L-1) (n = 6)
similar to phage treatment rat (193.50 + 34.735 IU L-1) (n =
6) (P > 0.05) on day 16. SGPT value of control rat (177.00 +
3 6.630 IU L-1) (n = 6) as much as phage treatment rat
(176.67 + 27.95 IU L-1) (n = 6) (P > 0.05) on day 16  (Table 7).
DISCUSSION
On the last day treatment, all of the treatments (phage
and control) had no significantly effect on the body
6.4 + 0.458
6.423 + 0.59
Figure 3. Effect of phage FR38 treatment on total protein values
of rat.
Table 6. Effect of phage treatment on blood cell of rat
Blood cell differentiation                                                        Phage FR38                                                                      Control
Erythrocyte (106/mm3)
Hb (%)
PCV (%)
Thrombocyte (106/mm3)
Leukocyte (thousand/mm3)
Neutrophil (%)
Eosinophils (%)
Basophil (%)
Lymphocyte (%)
Monocyt (%)
8.363 + 0.437a
12.643 + 0.798b
36.125 + 1.910c
119.167 + 13.86d
8.425 + 0.687e
20.667 + 9.331f
1.333 + 1.033g
0
76.167 + 8.377h
1.833 + 1.329i
8.922 + 1.358a
12.58 + 0.776b
37.125 + 2.032c
123.5 + 19.670d
8.2 + 2.905e
18.167 + 10.000f
1.333 + 0.512g
0
78.167 + 11.600h
2.333 + 1.584i
The same letter in each row indicated not significantly different at P > 0.05.
1.331 + 0.527
1.394 + 0.743
Figure 2. Effect phage FR38 treatment on creatinine value of rat.
Table 7. Effect of phage treatment on SGOT values of rat
Parameter                   Phage FR38                       Control
SGOT
SGPT
193.50 + 34.735a
176.67 + 27.955b
211.67 + 65.503a
177.00 + 36.630b
The same letter in each row indicated not significantly different
at P > 0.05.
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weight (P > 0.05) with the mean values of control was
250.47 g (n = 6) and the body growth phage treatment rat
was 255.83 g (n = 6). The mean values of normal body
weight of adult rat (for 40-60 days) are 200-250 g, but, it is
various depend on strain (Derelanko & Hollinger 2004).
The normal body weights of rat (2.5-3.5 month old) are
267-500 g (male) and 225-325 g (female) (Meredith & Anna
2002). All of the phage treatment rat shown that the body
growth rat were tend normal trend.
The result showed that organ weight of controls
treatment as weight as phage FR38 treatment, at
confidence level 99%, on day 16. This result was similar
to the previous studies on rat that reported by Derelanko
and Hollinger (2004), recorded that normal weight of right
kidney were 1.839 + 0.222 g and  left kidney were 1.717 +
0.155 g.
Erythrocyte, Hb, thrombocyte, and PCV values of rat
were normal (P > 0.05). Based on research on rat that
reported by Meredith and Anna (2002), the normal rat had
hemoglobin (Hb) values = (11.1-18) g dl-1 and Hematocrit
(PCV) = (36-52)%. It was similarly number from the previous
study by Derelanko and Hollinger (2004) that the normal
Hb of rat = (11-18) g dl-1; Erythrocyte = (6-10) x 106 mm-3,
and PCV = (34-48)%. This showed that the mean of Hb,
erythrocyte, PCV values of phage treatment rat were
normal.
The results point out that the differentiation of white
blood of control treatment was as much as in the phage
treatment, at confidence level 99%, on day 16.  It was not
significantly different (P > 0.05) than the control treatment.
The value was similarly from Derelanko and Hollinger
(2004) study showed that a normal rat had values of
leukocyte = (7-14) x 103 mm-3; neutrophils = (4-50)%;
lymphocytes = (40-95)%; monocytes = (0-8)%;
eosinophils = (0-2)%; basophils = (0-2)%; and  total protein
=  (5.9-8.4) g dl-1. The results mean that  the white blood
and total protein values of phage treatment rat were
normal; the phage FR38 had no effect on body rat.
Creatinin values of rat that had given phage treatment
were not significantly different than control as well. The
normal rat had a creatinin values = (0.39-2.29) mg dl-1
(Meredith & Anna 2002). The rat that had given phage
treatment had SGOT values = (193.50 ± 34.735) IU L-1 and
SGPT values = (176.67 + 27.955) IU L-1 were not significantly
different than control (P > 0.05).
In conclusion, all parameters studied above showed
not significantly different of P value between the two
groups of rat (P > 0.05). Therefore, those indicated that
the phage FR38 treatment did not effect to the rat body.
Paracetamol treatment on rat increased of  SGOT and SGPT
values (Jawi et al. 2008), but natural functional drink did
not effect on SGOT and SGPT values (Safithri et al. 2012).
ACKNOWLEDGEMENT
This research have been supported by Ministry of
National Education Republic of Indonesia through
Competitive Research Grant Team for Post Graduate
Program (multi years program of Bogor Agricultural
University), for which the authors are grateful.
REFERENCES
Abedon ST. 2008. Bacteriophage Ecology. Cambridge: Cambridge
Univ Pr. http://dx.doi.org/10.1017/CBO9780511541483
Abshire TG, Brown JE, Ezzell JW. 2005. Production and validation
of the use of gamma phage for identification of Bacillus
anthracis. J Clin Microbiol 43:4780-4788. http://dx.doi.org/
10.1128/JCM.43.9.4780-4788.2005
Ahmed R, Mistry PS, Jackson. 1995. Bacillus cereus phage typing
as an epidemiological tool in outbreaks of food poisoning. J
Clin Microbiol 33:636-640.
Anani H, Chen W, Pelton R. 2011. Biocontrol of L.
monocytogenes and E. coli in meat by using phages immobilized
on modified cellulose membranes. Appl Env Microbiol
77:6379-6387. http://dx.doi.org/10.1128/AEM.05493-11
Binetti AG, Reinheimer JA. 2000. Thermal and chemical
inactivation of indigenous Streptococcus thermophilus
bacteriophages isolated from Argentinian dairy plants. J Food
Prot 63:509-515.
Brenner FH, Stubbs AD, Farmer JJ. 1991. Phage typing of
Salmonella enteritidis in the United States. J Clin Microbiol
29:2817-2823.
Browska K, Aski M, Owczarek B. 2010. The effect phage lysate
on cancer cells in vitro. Clinic Exp Med 10:81-86. http://
dx.doi.org/10.1007/s10238-009-0066-9
Budiarti S, Pratiwi RH, Rusmana I. 2011. Infectivity of lytic
phage to enteropathogenic Escherichia coli from Diarrheal
patients in Indonesia. J US-China Med Sci 8:273-282.
Budynek P, Dabrowska K, Skaradzinski G, Górski A. 2010.
Bacteriophages and cancer. Arch Microbiol 192:315-320.
http://dx.doi.org/10.1007/s00203-010-0559-7
Bull JJ, Otto G, Molineaux IJ. 2011. In vivo growth rates are
poorly correlated with phage therapy success in a mouse
infection model. Antimicrob Agents Chem 56:949-954. http:/
/dx.doi.org/10.1128/AAC.05842-11
Cairns T, Payne J. 2009. Quantitative models of in vitro phage-
host dynamics and their application to phage therapy. PLoS
Pathogen J 5:20-25.
Castillo A, Lopez M, Hidalgo G, Vitella. 2006. Salmonella and
Shigella in orange juice and fresh orange. J Food Protect
69:2595-2599.
Castro D, Moriñigo MA, Manzanares EM, Cornax R. 1991.
Development and application of a new scheme of phages for
typing and differentiating Salmonella strains from different
sources. J Clin Microbiol 30:1418-1423.
Chakrabarti AK, Ghosh AN, Nair GB. 2000. Bacteriology
development and evaluation of a phage typing scheme for
Vibrio cholerae O139. J Clin Microbiol 38:44-49.
Clokie MRJ, Kropinski AM. 2009. Bacteriophages: Method and
Protocols. UK: Humana Pr. http://dx.doi.org/10.1007/978-
1-60327-565-1
Delibato E. 2006. Development of a SYBR green real-time PCR
and multichannel electrochemical immunosensor for specific
detection of Salmonella enterica. Anal Lett J 39:1611-1620.
http://dx.doi.org/10.1080/00032710600713354
Derelanko MJ, Hollinger MA. 2004. Handbook Toxicology (2nd
Ed). USA: CRC Pr.
Djojosoebagio S. 2007. Veterinary Physiology. Bogor: Bogor
Agricultural Univ.
Duijkeren V, Wannet WJ, Houwers C. 2002. Serotype and phage
type distribution of Salmonella strains isolated from humans,
cattle, pigs, and chickens in the Netherlands from 1984 to
2001. J Clin Microbiol 40:3980-3985. http://dx.doi.org/
10.1128/JCM.40.11.3980-3985.2002
Edgar R, Friedman R, Mor SM. 2011. Reversing bacterial resistance
to antibiotic by phages-mediated delivery of dominant
sensitive genes. Appl  Env Microbiol 78:3744-3751.
Ellis DE, Whitman PA, Marshall RT. 1973. Effects homologous
bacteriophage on growth of Pseudomonas fragi WY in milk.
Appl Env Microbiol 25:24-27.
Flaherty JE, Jones JB, Harbaugh BK, Somodi GC, Jackson LE.
2000. Control of bacterial spot on tomato in the greenhouse
and field with bacteriophages. Hort Sci 35:882-884.
Vol. 19, 2012                                                                             The Lityc Phage of Salmonella sp.     135
Foddai A, Strain S, Whitlock RH, Elliott CT, Irene R, Grant.
2011. Clinical veterinary microbiology notes: application of
a peptide-mediated magnetic separation-phage assay for
detection of viable Mycobacterium vium  subsp.
paratuberculosis to bovine bulk tank milk and feces samples. J
Clin Microbiol 49:2017-2019. http://dx.doi.org/10.1128/
JCM.00429-11
Gast RK, Benson ST. 1995. Comparative virulence for chicks of
Salmonella. Avian Disease J 10:567-574. http://dx.doi.org/
10.2307/1591810
Ghaemi A, Gill P, Jahromy SR, Roohvand F. 2010. Recombinant
λ-Phage Nanobioparticles for tumor therapy in mice models.
Gen Vaccine Therapy J 8:3-10. http://dx.doi.org/10.1186/
1479-0556-8-3
Greer G. 2005. Bacteriophage control of foodborne bacteria. J
Food Prot 68:1102-1111.
Izzo MM, House JK. 2011. Prevalency of mayor enteric pathogen
in Australian dairy calves. Australian Veterinary J 169:8-5.
Jawi K, Indrayani S, Sumardika, Yasa. 2008. Paracetamol effect
on SGPT and SGOT of mice. Medicine J 21:57-59.
Kennedy JE. 1986. Methodology for enumeration of coliphage in
food. App Environ Microbiol 51:956-962.
Kim JW, Dutta V, Elhanafi D. 2012. A novel restriction-
modification system is responsible for temperature-dependent
phage resistance in L. monocytogenes. Appl Env Microbiol
78:1995-2004. http://dx.doi.org/10.1128/AEM.07086-11
Laanto E, Sundberg LR, Bamford KH. 2011. Phage specificity of
the fresh water fish pathogen F. columnar. Appl Env Microbiol
77:7868-7872. http://dx.doi.org/10.1128/AEM.05574-11
Leverrentz B, Conway WS, Alavidze Z. 2001. Examination of
bacteriophage as a biocontrol method for Salmonella on fresh-
cut fruit. J Food Prot 64:1116-1121.
Leverrentz B, Conway WS, Jannisiewics W, Camp MJ. 2004.
Optimizing concentration and timing phage spray on honeydew
melon. J Food Prot 67:1682-1686.
Li R, Mustapha. 2005. Application PCR for detection E. coli,
Shigella and Salmonella in raw and ready to eat meat product.
Meat Sci J 20:402-406.
Lu Z, Breidt F, Flemming JR. 2003a. Bacteriophage ecology in
commercial sauerkraut fermentation. Appl Environ Microbiol
69:3192-3202. http://dx.doi.org/10.1128/AEM.69.6.3192-
3202.2003
Lu Z, Breidt F, Flemming JR. 2003b.  Isolation and characterization
of L. Plantarun bacteriophage. From cucumbar fermentation.
Int J Food Microbiol 84:225-235. http://dx.doi.org/10.1016/
S0168-1605(03)00111-9
Maura D, Debarbieux L. 2011. Phages as twenty-first century
antibacterial tools for food and medicine. Appl Microbiol
Biotech J 90:851-860. http://dx.doi.org/10.1007/s00253-011-
3227-1
Meredith, Anna. 2002. BSAVA Manual of Exotic Pets (4th Ed).
British: BSAVA Pr.
Murchan S, Aucken HM, O’Neill GL. 2004. Emergence, spread,
and characterization of phage variants of epidemic
methicillin-resistant Staphylococcus aureus 16 in England
and Wales. J Clin Microbiol 42:5154-5160. http://dx.doi.org/
10.1128/JCM.42.11.5154-5160.2004
Nerney R, Kambashi R, Kinkese J. 2004. Mycobacteriology and
aerobic actinomycetes development of a bacteriophage  phage
replication assay for diagnosis of pulmonary tuberculosis. J
Clin Microbiol 42:52115-52120.
O’Neill GL, Murchan S, Setas AG. 2001. Epidemiology
identification and characterization of phage variants of a strain
of epidemic methicillin-resistant Staphylococcus aureus
(EMRSA-15). J Clin Microbiol 39:1540-1548. http://dx.doi.
org/10.1128/JCM.39.4.1540-1548.2001
Pang S, Octavia S, Reevers PR. 2011. Genetic relationship
polymorphism typing of Salmonella enterica. J Clin Microbiol
50:3727-3734.
Ray B. 2001. Fundamental Food Microbiology. Washington DC:
CRC Pr.
Rode TM, Axelsson L, Granum PE. 2011. High stability of stx2
phage in food and under food processing condition. Appl Env
Microbiol 77:5336-5341. http://dx.doi.org/10.1128/AEM.
00180-11
Safithri M, Yasni S, Bintang M, Ranti AS. 2012. Toxicity study of
antidiabetics functional drink of piper crocatum and
cinnamomum burmannii. Hayati J Biosci 19:31-36. http://
dx.doi.org/10.4308/hjb.19.1.31
Schofield DA, Molineux IJ, Westwater C. 2009. Diagnostic
bioluminescent phage for detection of Yersinia pestis. J Clin
Microbiol 47:3887-3894. http://dx.doi.org/10.1128/JCM.
01533-09
Sillankorva S, Shaburova O, Santos S. 2010. Salmonella enteritidis
phage candidates for phage therapy of poultry. J Appl
Microbiol 108:1175-1187. http://dx.doi.org/10.1111/j.1365-
2672.2009.04549.x
Tadesse G, Ashenafi M, Ephraim E. 2005. Survival E. coli, Shigella
and Salmonella in Fermenting Borde (beverage). Meat Sci J
5:189-196.
Zhuang Z, Yu L, Mustapha A. 2005. Simultaneous detection of E.
coli, Salmonella, Shigella in apple cider. J Food Protect
67:27-33.
136     SARTIKA  ET AL.                                                                                                                                           HAYATI J Biosci
